Verruciform xanthoma in association with Milroy disease and leaky capillary syndrome

Pediatric Dermatology

Volumn 20, Issue 1, 2003, Pages 44-47

  Wu, Jashin J ^a   Wagner, Annette M ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFALEXIN; SALICYLIC ACID;

ACANTHOSIS; ADULT; ARTICLE; CASE REPORT; CAUCASIAN; CELLULITIS; CLINICAL FEATURE; CRYOTHERAPY; CURETTAGE; DESICCATION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOOT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEAKY CAPILLARY SYNDROME; LEG COMPRESSION; LIPID BLOOD LEVEL; MALE; MILROY DISEASE; PAPULE; PRIORITY JOURNAL; PUNCH BIOPSY; SCHOOL CHILD; SKIN BIOPSY; TREATMENT OUTCOME; VASCULAR DISEASE; VERRUCA VULGARIS; VERRUCIFORM XANTHOMA; XANTHOMA; ADOLESCENT; CAPILLARY; CHILD; FOLLOW UP; IMMUNOHISTOCHEMISTRY; LYMPHEDEMA; NEEDLE BIOPSY; PATHOLOGY; RARE DISEASE; RISK ASSESSMENT; SKIN DISEASE; SYNDROME; TOE; XANTHOMATOSIS;

ADOLESCENT; BIOPSY, NEEDLE; CAPILLARIES; CHILD; FEMALE; FOLLOW-UP STUDIES; FOOT DERMATOSES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHEDEMA; MALE; RARE DISEASES; RISK ASSESSMENT; SYNDROME; TOES; VASCULAR DISEASES; XANTHOMATOSIS;

EID: 0037531299     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1470.2003.03010.x     Document Type: Article

References (21)

1. Shafer WG. Verruciform xanthoma. Oral Surg 1971; 31:784-789.
2. Nowparast B, Howell FV, Rick GM. Verruciform xanthoma: a clinicopathologic review and report of fifty-four cases. Oral Surg 1981;51:619-625.
3. Takehana S, Kameyama Y, Fukaya M, Kawai T. Verruciform xanthoma of the gingival: report of three cases. Oral Maxillofac Surg 1989;47:1079-1081.
4. Elder D, Elenitsas R, Jaworsky C, Johnson B Jr, eds. Lever's histopathology of the skin, 8th ed. Philadelphia: Lippincott-Raven, 1997:606-607.
5. Zegarelli DJ, Zegarelli-Schmidt EC, Zegarelli EV. Verruci-form xanthoma: a clinical, light microscopic, and electron microscopic study of two cases. Oral Surg 1974;38: 725-734.
6. Zegarelli DJ, Zegarelli-Schmidt EC, Zegarelli EV. Verruci-form xanthoma: further light and electron microscopic studies, with the addition of a third case. Oral Surg 1975;40:246-256.
7. Cairns RJ. Lymphangioma circumscriptum. Br J Dermatol 1963;75:123.
8. Coburn JG. Extracellular cholesterosis and lymphedema. Br J Dermatol 1963;75:128-129.
9. Goldrick RB, Ahrens EH Jr. Unilateral chylous lymphedema and xanthomastosis: a study of factors governing the flow of intestinal lymph. Am J Med 1964;37:610-622.
10. Polano MK, Prins FJ. Lymphagiektasien und sekundare xanthomatosis. Hautartz 1965;16:86-88.
11. Hunter JAA, Morely WN, Peterkin GAG. Xanthomatosis secondary to lymphedema. Trans St John Hosp Dermatol Soc 1970;56:143-148.
12. Woolling KR, Jenkins RE, Dolan PA, Evans PV. Localized xanthomas in lymphedema praecox. JAMA 1970;211:1372-1374.
13. Berger BW, Kantor I, Maier HS. Xanthomatosis and lymphedema. Arch Dermatol 1972;105:730-733.
14. Chyu J, Medenica M, Whitney DH. Verruciform xanthoma of the lower extremity-report of a case and review of literature. J Am Acad Dermatol 1987;17:695-697.
15. Snider RL. Verruciform xanthomas and lymphedema. J Am Acad Dermatol 1992;27:1021-1023.
16. Huguet P, Toran N, Tarragona J. Cutaneous verruciform xanthoma arising on a congenital lymphoedematous leg. Histopathology 1995;26:277-279.
17. Anzilotti MG, Calderon PE. Xanthomatosis associated with lymphedema praecox in a child with congenital pulmonary hypertension. J Am Acad Dermatol 1997; 36:631-633.
18. Schirger A. Idiopathic lymphedema: review of 131 cases. JAMA 1962;182:14.
19. Dubin HV, Creehan EP, Headington JT. Lymphangiosarcoma and congenital lymphedema of the extremity. Arch Dermatol 1974;110:608.
20. Hanto DW, Harty JT, Hoffman RA, Simmons RL. Evidence that secondary mixed leukocyte culture supernatant mediates changes in cellular recruitment, blood flow, and vascular permeability. Transplantation 1986;42: 621-627.
21. Fields KK, Elfenbein GJ, Perkins JB, et al. High-dose ifosfamide/carboplatin/etoposide, maximum tolerable doses, toxicities, and hematopoietic recovery after autologous stem cell reinfusion. Semin Oncol 1994;21:86-92.